Alzheimer; News from the web:
A team of international researchers, led by UC San Francisco, has completed the first large-scale study of posterior cortical atrophy, a baffling constellation of visuospatial symptoms that present as the first signs of Alzheimer’s disease. These symptoms occur in up to 10% of cases of Alzheimer’s disease.
Read all about it HERE
Alzheimer; News from the web:
Today, we are living history: the U.S. Food and Drug Administration (FDA) granted traditional approval of lecanemab, sold under the brand name Leqembi, for the treatment of early-stage Alzheimer’s disease. This is the first traditional approval granted for an Alzheimer’s treatment that changes the underlying course of the disease. Learn more here.
In addition, the Centers for Medicare & Medicaid Services (CMS) announced it will cover the treatment through Medicare. Read our statement here.
Read all about it HERE
Alzheimer; News from the web:
NIH-supported research has identified a type of immune cell that helps remove waste products in the brain. Boosting these immune cells in aged mice improved the clearance of proteins associated with Alzheimer’s disease. The findings suggest potential prevention and treatment strategies for Alzheimer’s disease and related disorders.
Read all about it HERE
Alzheimer; News from the web:
Researchers have discovered two novel genes that increase an individual’s risk of developing Alzheimer’s disease. The researchers used a technique called exome sequencing to identify the genes. Exome sequencing is able to identify rare mutations. The discovery brings scientists closer to finding treatment options and preventative measures for the disease.
Read all about it HERE
Alzheimer; News from the web:
The Alzheimer’s Association is disappointed by the topline Phase 3 data reported today by Genentech and Roche from the GRADUATE Phase 3 global clinical trials of gantenerumab. However, these results will contribute to our understanding of this devastating and fatal disease. Although the drug did not meet its primary endpoint, the trials further illustrate the relationship between removal of beta-amyloid and reduction of clinical decline.
Read all about it HERE
Alzheimer; News from the web:
Nose-picking is a habit that is generally seen as unpleasant, but harmless. However, research from Griffith University in Queensland, Australia, suggests that the activity might not be as risk-free as previously thought.
The research, published in Nature Scientific ReportsTrusted Source, shows that by damaging the nasal cavity in mice, bacteria can enter the brain through the olfactory nerve.
Read all about it HERE